Deepak Bhatt, MD: Impact of COVID-19 on Clinical Trials in Cardiology
Deepak Bhatt, MD, offers perspective on how the ongoing pandemic has impacted clinical trials in the cardiovascular space.
Related Articles
Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation
Comment on the article ‘Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial’, which was published in Nature Med; ht
Do patients benefit from omega-3 fatty acids?
Abstract. Omega-3 fatty acids (O3FAs) possess beneficial properties for cardiovascular (CV) health and elevated O3FA levels are associated with lower incident r
Can intermittent fasting have negative effects? Study finds higher risk of cardiovascular death
Restricting eating to eight or fewer hours a day, a type of intermittent fasting, may raise the risk of dying prematurely from heart disease over…
Systems, hospitals with the most top heart physicians: Castle Connolly
Discover the top heart and vascular care physicians in New York according to Castle Connolly’s 2024 accolades.
World’s best cardiology hospitals, per Newsweek
Discover the top 10 cardiology hospitals in the world, with seven based in the U.S. according to Newsweek’s 2024
World’s best cardiology hospitals, per Newsweek
Discover the top 10 cardiology hospitals in the world, with seven based in the U.S. according to Newsweek’s 2024
Marijuana use as little as once per month linked to heart attack and stroke risk
The new study is among the largest to show a connection between marijuana and cardiovascular health in people who don’t also smoke tobacco.
The Legends Colloquium: A Conversation Between Eugene Braunwald and Valentin Fuster
∗Address for correspondence: Dr Deepak L. Bhatt, Director, Mount Sinai Fuster Heart Hospital, Dr Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at…
Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry
Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y12 inhibitor…
Do patients benefit from omega-3 fatty acids?
Abstract. Omega-3 fatty acids (O3FAs) possess beneficial properties for cardiovascular (CV) health and elevated O3FA levels are associated with lower incident r